Fig. 1

Expression levels of CDKN2B-AS1 in DN and HG-induced HMCs. a QRT-PCR was conducted to examine CDKN2B-AS1 expression in serum of 34 DN patients and 34 healthy controls, and GADPH was selected as an internal reference. b The expression levels of CDKN2B-AS1 in HMCs after HG (30 mM) or low glucose (5 mM) treatment were measured with qRT-PCR, and GADPH was selected as an internal reference. The experiments were repeated 3 times, and data were presented as mean ± standard deviation. ***P < 0.001 and ****P < 0.0001